A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution

Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardive dyskinesia with dramatic evolution in a patient with several risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Heitzmann, Edwige, Javelot, Hervé, Weiner, Luisa, Michel, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080510/
https://www.ncbi.nlm.nih.gov/pubmed/27818825
http://dx.doi.org/10.1155/2016/7031245
Descripción
Sumario:Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardive dyskinesia with dramatic evolution in a patient with several risk factors, including older age and exposure to antipsychotic over a period longer than six months. This case and its dramatic evolution, associated with other cases recently published, suggest reconsidering the real risk of tardive dyskinesia associated with aripiprazole, particularly in the elderly.

Ejemplares similares